The IRA’s drug pricing provisions are viewed favorably by voters. Accordingly, the industry’s legal challenge to block Medicare from price negotiations is unpopular.
The IRA’s drug pricing provisions are viewed favorably by voters. Accordingly, the industry’s legal challenge to block Medicare from price negotiations is unpopular.